ArticleEuropean physical journal plus2022
Omicron: a mysterious variant of concern.
Article in European physical journal plus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
44 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The risk of mortality and severe illness in patients infected with the omicron variant relative to delta variant of SARS-CoV-2: a systematic review and meta-analysis.Irish journal of medical science · 2023Pooled it
- Adaptive Fourier decomposition-based time-frequency analysis of COVID-19 epidemic trends and policy interventions in Washington D.C., with comparative validation in London.Journal of thoracic disease · 2026Article
- Article
- Uncovering potent natural phytochemicals targeting SARS-COV-2 spike protein variants: molecular dynamics insights.Scientific reports · 2025Article
- Analysis of six consecutive waves of ICU-admitted COVID-19 patients: key findings and insights from a Portuguese population.GeroScience · 2025Article
- Analysis of Structures of SARS-CoV-2 Papain-like Protease Bound with Ligands Unveils Structural Features for Inhibiting the Enzyme.Molecules (Basel, Switzerland) · 2025Review
- Early symptoms and 12-week follow-up of pediatric omicron infections during the Beijing outbreak.Frontiers in pediatrics · 2025Article
- Insights into the role of dynamical features in protein complex formation: The case of SARS-CoV-2 spike binding with ACE2.Computational and structural biotechnology journal · 2025Article
- The influence of Omicron on vaccine efficacy and durability: a neurology perspective.Clinical and experimental vaccine research · 2024Review
- Chronic Obstructive Pulmonary Disease and the Omicron Variant of COVID-19 Prognosis: A Retrospective Cohort Study.Cureus · 2024Article
- Motifs in SARS-CoV-2 evolution.RNA (New York, N.Y.) · 2023Article
- Association between Gross National Income per capita and COVID-19 vaccination coverage: a global ecological study.BMC public health · 2023Article
- Article
- Association of Social Vulnerability and COVID-19 Mortality Rates in Texas between 15 March 2020, and 21 July 2022: An Ecological Analysis.International journal of environmental research and public health · 2023Article
- Dynamics of SARS-CoV-2 variants characterized during different COVID-19 waves in Mali.IJID regions · 2023Article
- Dimensional study of COVID-19 via fractal functions.The European physical journal. Special topics · 2023Article
- Autoimmunity, COVID-19 Omicron Variant, and Olfactory Dysfunction: A Literature Review.Diagnostics (Basel, Switzerland) · 2023Review
- Convergent Evolution Dynamics of SARS-CoV-2 and HIV Surface Envelope Glycoproteins Driven by Host Cell Surface Receptors and Lipid Rafts: Lessons for the Future.International journal of molecular sciences · 2023Review
- Review
- Short Sleep Duration is Associated with Prolonged Virus Shedding in SARS-CoV-2 Omicron-Infected Patients.Nature and science of sleep · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Omicron (B.1.1.529), a highly mutated SARS-CoV-2 variant, has emerged in the south of African continent in the November 2021. The spike protein of Omicron has 26 amino acid mutations, which makes it distinct from the other variants of concern. Researches are underway to know the virulence and transmission rate of Omicron variant. In this letter, the seven-day moving average of most affected Omicron variant countries Denmark, Germany, India, Netherlands, South Africa and UK has been investigated and compared with each other. Further, the seven-day average of daily positive Omicron cases of the prescribed countries has been predicted for the months of December 2021, January 2022 and February 2022 using the fractal interpolation method. Results elucidate that the curve of daily positive case follows the same pattern even though the new variant of concern, Omicron added in the existing variants.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.